Naotake Tanaka

4PUBLICATIONS
40CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 28, 2025
Bevacizumab in frontline chemotherapy improved the survival outcome for advanced ovarian clear cell carcinoma: a multicenter retrospective analysis.

Shinichi Tate, Toshiyuki Seki, Kyoko Nishikimi

|Jul 26, 2024
Niraparib in Japanese patients with platinum-sensitive recurrent ovarian cancer: final results of a multicenter phase 2 study.

Hiroaki Itamochi, Nobuhiro Takeshima, Junzo Hamanishi

|Jun 26, 2021
Kras activation in endometrial organoids drives cellular transformation and epithelial-mesenchymal transition.

Yoshiaki Maru, Naotake Tanaka, Yasutoshi Tatsumi

|Jan 20, 2021
Phase 2 single-arm study on the safety of maintenance niraparib in Japanese patients with platinum-sensitive relapsed ovarian cancer.

Kazuhiro Takehara, Takashi Matsumoto, Junzo Hamanishi

Pageof 1

Frequent Collaborators

2 joint publications

Kazuhiro Takehara

2 joint publications

Junzo Hamanishi

2 joint publications

Kosei Hasegawa

2 joint publications

Motoki Matsuura